Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
Completed · Phase 1
Conditions studied: Type 2 Diabetes Mellitus
In brief
The purpose of this study is to examine the drug-drug interaction when given the study drug, bexagliflozin, with three commonly prescribed medications, probenecid, verapamil or rifampin. The study is to evaluate how safe the study drug is and how well the study drug is tolerated when taken with probenecid, verapamil or rifampin.
Key facts
- Study ID
- NCT03296800
- Run by
- Theracos
- People needed
- 48
- Starts
- 2017-09-27
- Expected to finish
- 2017-12-06
- Last updated by the study team
- 2021-07-01
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Covance Clinical Research Unit — Daytona Beach, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.